Background
==========

Percutaneous endoscopic gastrostomy (PEG) is considered to be a safe procedure for establishing a route of feeding and nutrition support in patients requiring long-term enteral nutrition \[[@b1-amjcaserep-17-963]\]. However, serious complications including bleeding, internal organ injury, aspiration, and perforation can occur in 1.5% to 4% of cases \[[@b2-amjcaserep-17-963]\]. Gastric intramural hematoma (GIH) is a rare condition usually resulting from coagulopathy, trauma, or endoscopic biopsy \[[@b3-amjcaserep-17-963]\]. We present the second case report in the literature of a uremic patient who developed intraoperative GIH due to PEG tube placement and was successfully managed with conservative therapy.

Case Report
===========

A 73-year-old Hispanic male with a history of stage IV chronic kidney disease and three-vessel coronary artery disease was admitted for coronary artery bypass graft surgery and mitral valve repair. On post-operative day two, the patient developed cardiac tamponade and subsequently progressed to a cardiac arrest while temporary pacing wires were being removed. Advanced cardiovascular life support and emergent exploratory sternotomy were performed, and the patient was transferred to the intensive care unit (ICU) for further care.

During the patient's ICU admission, his renal failure progressed, requiring hemodialysis. A nasogastric tube was placed on post-operative day two for establishing early enteral nutrition. PEG tube insertion was suggested given his cognitive impairment and poor swallowing function on the Modified Barium Swallow test. His coagulation profile prior to the procedure revealed an international normalized ratio of 1.04 and partial thromboplastin time of 36 seconds. A complete blood count showed a hemoglobin of 11.6 grams per deciliter, a hematocrit of 34.9%, and 281×10^3^ platelets per microliter. His blood urea nitrogen was 55 milligrams/deciliter, and his serum creatinine was 5.22 milligrams/deciliter. The patient was taking aspirin 81 mg per day due to recent cardiac surgery, but was not on any anticoagulant agents. He also did not have a history of coagulopathy.

PEG tube insertion was performed on post-operative day eight under intravenous anesthesia. The esophagogastroduodenoscopy (EGD) was accomplished without difficulty, revealing diffuse moderately erythematous mucosa without bleeding in the gastric antrum. While attempting PEG tube placement, a rapidly expanding hematoma ([Figure 1](#f1-amjcaserep-17-963){ref-type="fig"}) developed at the needle insertion site. The procedure was stopped and the patient was sent back to the ICU with a nasogastric tube. A single dose of intravenous desmopressin (0.3 microgram/kilogram) was administered under the suspicion of uremic bleeding.

No further gastrointestinal bleeding events were noted. To assess platelet function, a platelet function assay (PFA) was ordered after desmopressin injection. PFA collagen/epinephrine closure time was 195 seconds (normal \<174 seconds), and collagen/ADP closure time was 76 seconds (normal \<120 seconds), indicating platelet dysfunction due to either aspirin or uremia. Aspirin was discontinued, and he was monitored with a daily complete blood count and metabolic panel. Three days later the patient underwent a second attempt at PEG tube placement. PFA collagen/epinephrine closure time prior to this procedure had gone down to 141 seconds, possibly due to withholding aspirin and an improvement in renal function. EGD showed an area of flat, bluish gastric submucosal bruising at the site of the previous hematoma ([Figure 2](#f2-amjcaserep-17-963){ref-type="fig"}). The PEG tube was placed successfully at an adjacent site. Over the course of the following month, the patient continued to undergo feeding through the PEG tube with no adverse events.

Discussion
==========

Intramural hematoma of the gastrointestinal tract is an uncommon condition that primarily occurs in the esophagus or duodenum \[[@b3-amjcaserep-17-963]\]. GIH has rarely been described in the current literature. In addition to 26 cases reviewed by Dhawan et al. \[[@b3-amjcaserep-17-963]\] in 2009, we found 8 more cases reporting GIH. Jowett et al. reported the only case of iatrogenic gastric wall hematoma by PEG insertion that was managed conservatively in a uremic patient \[[@b4-amjcaserep-17-963]\]. Hematoma was diagnosed in that patient by endoscopic ultrasound and gastroscopy when she presented with coffee ground hematemesis 6 hours after the procedure. The most common contributing factor to GIH is a bleeding diathesis, including warfarin use \[[@b5-amjcaserep-17-963]\] and hemophilia ([Figure 3](#f3-amjcaserep-17-963){ref-type="fig"}). Among all reported cases associated with warfarin use, only one case \[[@b6-amjcaserep-17-963]\] needed transcatheter arterial embolization, while others were managed conservatively through coagulopathy reversal and blood transfusion. GIH can also result from aneurysm, trauma peptic ulcer, pancreatitis, or spontaneous hematoma \[[@b3-amjcaserep-17-963]\]. With the development of different endoscopic procedures, cases that lead to GIH following ultrasound-guided fine-needle biopsy \[[@b7-amjcaserep-17-963]\], endoscopic mucosal resection \[[@b8-amjcaserep-17-963]\], or argon plasma coagulation \[[@b9-amjcaserep-17-963]\] were noted. It is hypothesized that damage to small vessels contained within the deep submucosa/mucosa layer occurred during these procedures, resulting in hematoma formation. All 3 cases related to endoscopic procedures required endoscopic or open surgical interventions to achieve hemostasis. In the current literature, 16 out of 34 (47%) cases required invasive procedures to achieve hemostasis, with most of them having underlying structural damage or abnormalities. In our case, damage to arterioles in the submucosa or muscularis layers during needle insertion possibly led to hematoma formation in the setting of platelet dysfunction. Fortunately, the bleeding stopped spontaneously and our patient didn't require further intervention.

According to a recent published meta-analysis, gastrointestinal bleeding developed in 2.67% of patients undergoing PEG tube placement \[[@b10-amjcaserep-17-963]\]. While most of these cases can be managed conservatively with placement of packing material, application of pressure, or placement of a stitch at the bleeding sites, damage to major vessels leading to death does occur. One case reported the formation of a fatal retroperitoneal hemorrhage due to injury to the splenic and superior mesenteric veins \[[@b11-amjcaserep-17-963]\]. Another unfortunate case resulted in death due to perforation of the gastric artery \[[@b12-amjcaserep-17-963]\].

Conclusions
===========

Learning from this case, physicians should be aware of the risks of bleeding while performing seemingly low-risk procedures. Even with normal coagulation profiles, patients with chronic kidney disease can bleed due to platelet dysfunction. Aspirin discontinuation, although not mandatory before PEG tube insertion, should be considered in patients with a potential risk of bleeding. Endoscopists should be keenly alert of the potential for serious complications during and following percutaneous endoscopic gastrostomy.
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![(**A**) First attempt at percutaneous endoscopic gastrostomy. (**B**) An expanding hematoma developed at needle insertion site.](amjcaserep-17-963-g001){#f1-amjcaserep-17-963}

![Second attempt at percutaneous endoscopic gastrostomy. Blue staining within gastric wall at site of previous hematoma.](amjcaserep-17-963-g002){#f2-amjcaserep-17-963}

![Causes of gastric intramural hematoma: 34 cases from 1970--2015. Data were derived from a study published by Dhawan et al. \[[@b3-amjcaserep-17-963]\] and also from other published case reports \[[@b7-amjcaserep-17-963]--[@b9-amjcaserep-17-963],[@b13-amjcaserep-17-963]--[@b19-amjcaserep-17-963]\].](amjcaserep-17-963-g003){#f3-amjcaserep-17-963}
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